Head and Neck Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Head and Neck
| Protocol | COG ARAR2221 |
|---|---|
| Cancer Type: | Nasopharyngeal Carcinoma (NPC) |
| Fast Facts |
COG ARAR2221
A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
Patients must be ≤ 21 years of age at the time of study enrollment.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
